中华围产医学杂志
中華圍產醫學雜誌
중화위산의학잡지
CHINESE JOURNAL OF PERINATAL MEDICINE
2011年
7期
425-430
,共6页
陈涵强%杨长仪%杨文庆%石惠英%林云峰
陳涵彊%楊長儀%楊文慶%石惠英%林雲峰
진함강%양장의%양문경%석혜영%림운봉
婴儿,早产%婴儿,极低出生体重%动脉导管未闭%吲哚美辛%胸腔镜检查
嬰兒,早產%嬰兒,極低齣生體重%動脈導管未閉%吲哚美辛%胸腔鏡檢查
영인,조산%영인,겁저출생체중%동맥도관미폐%신타미신%흉강경검사
Infant,premature%Infant,very low birth weight%Ductus arteriosus,patent%Indomethacin%Thoracoscopy
目的探讨极低出生体重早产儿有临床表现的动脉导管未闭的治疗方法方法 本研究为前瞻性队列研究.2008年1月1日至2010年12月31日间出生体重<1500 g的确诊有临床表现的动脉导管未闭早产儿78例,其中42例采用口服吲哚美辛治疗者作为治疗组,36例未治疗者为对照组.观察吲哚美辛的疗效、副作用以及对早产儿的近远期预后.结果治疗组及对照组在性别比例、胎龄、动脉导管直径、合并心力衰竭、败血症、新生儿呼吸窘迫综合征、脑室内出血的差异均无统计学意义(P均>0.05).治疗组治疗后动脉导管关闭33例,关闭率为78.6%,高于对照组,自发关闭9例,关闭率25.0%,差异有统计学意义(χ2=22.39,P=0.000).治疗组治疗前后的血肌酐、血小板差异无统计学意义(P均>0.05).治疗组较对照组有较少的脑室内出血发生比例(z=1.167,P=0.030)、较短的总用氧时间[分别为(8.0±5.5) d和(13.3±9.3) d,t=2.225,P=0.032]及住院时间[(39.0±7.7) d和(43.6±10.6) d,t=2.229,P=0.029],且支气管肺发育不良、坏死性小肠结肠炎的发生情况组间差异无统计学意义(P均>0.05).治疗组中有5例药物治疗失败后使用胸腔镜钳闭动脉导管,术后3例发生肺部感染,1例出现胸腔积液,无死亡及气胸发生.结论极低出生体重早产儿有临床表现的动脉导管未闭应积极干预,口服吲哚美辛可有效关闭动脉导管,胸腔镜钳闭动脉导管可作为药物治疗失败后的一种选择.
目的探討極低齣生體重早產兒有臨床錶現的動脈導管未閉的治療方法方法 本研究為前瞻性隊列研究.2008年1月1日至2010年12月31日間齣生體重<1500 g的確診有臨床錶現的動脈導管未閉早產兒78例,其中42例採用口服吲哚美辛治療者作為治療組,36例未治療者為對照組.觀察吲哚美辛的療效、副作用以及對早產兒的近遠期預後.結果治療組及對照組在性彆比例、胎齡、動脈導管直徑、閤併心力衰竭、敗血癥、新生兒呼吸窘迫綜閤徵、腦室內齣血的差異均無統計學意義(P均>0.05).治療組治療後動脈導管關閉33例,關閉率為78.6%,高于對照組,自髮關閉9例,關閉率25.0%,差異有統計學意義(χ2=22.39,P=0.000).治療組治療前後的血肌酐、血小闆差異無統計學意義(P均>0.05).治療組較對照組有較少的腦室內齣血髮生比例(z=1.167,P=0.030)、較短的總用氧時間[分彆為(8.0±5.5) d和(13.3±9.3) d,t=2.225,P=0.032]及住院時間[(39.0±7.7) d和(43.6±10.6) d,t=2.229,P=0.029],且支氣管肺髮育不良、壞死性小腸結腸炎的髮生情況組間差異無統計學意義(P均>0.05).治療組中有5例藥物治療失敗後使用胸腔鏡鉗閉動脈導管,術後3例髮生肺部感染,1例齣現胸腔積液,無死亡及氣胸髮生.結論極低齣生體重早產兒有臨床錶現的動脈導管未閉應積極榦預,口服吲哚美辛可有效關閉動脈導管,胸腔鏡鉗閉動脈導管可作為藥物治療失敗後的一種選擇.
목적탐토겁저출생체중조산인유림상표현적동맥도관미폐적치료방법방법 본연구위전첨성대렬연구.2008년1월1일지2010년12월31일간출생체중<1500 g적학진유림상표현적동맥도관미폐조산인78례,기중42례채용구복신타미신치료자작위치료조,36례미치료자위대조조.관찰신타미신적료효、부작용이급대조산인적근원기예후.결과치료조급대조조재성별비례、태령、동맥도관직경、합병심력쇠갈、패혈증、신생인호흡군박종합정、뇌실내출혈적차이균무통계학의의(P균>0.05).치료조치료후동맥도관관폐33례,관폐솔위78.6%,고우대조조,자발관폐9례,관폐솔25.0%,차이유통계학의의(χ2=22.39,P=0.000).치료조치료전후적혈기항、혈소판차이무통계학의의(P균>0.05).치료조교대조조유교소적뇌실내출혈발생비례(z=1.167,P=0.030)、교단적총용양시간[분별위(8.0±5.5) d화(13.3±9.3) d,t=2.225,P=0.032]급주원시간[(39.0±7.7) d화(43.6±10.6) d,t=2.229,P=0.029],차지기관폐발육불량、배사성소장결장염적발생정황조간차이무통계학의의(P균>0.05).치료조중유5례약물치료실패후사용흉강경겸폐동맥도관,술후3례발생폐부감염,1례출현흉강적액,무사망급기흉발생.결론겁저출생체중조산인유림상표현적동맥도관미폐응적겁간예,구복신타미신가유효관폐동맥도관,흉강경겸폐동맥도관가작위약물치료실패후적일충선택.
Objective To investigate the treatment of symptomatic patent ductus arteriosus (PDA) in very low birth weight preterm infants. Methods From January 1, 2008 to December 31, 2010, 78 very low birth weight preterm infants (birth weight<1500 g) were diagnosed as symptomatic PDA. Among which, 42 cases administered orally with indomethacin (0.2 mg/kg, every 12 hrs for three times) were taken as treatment group, while five cases in this group who failed to indomethacin treatment were interrupted with video-assisted thoracoscopic surgery. And 36 cases who did not receive treatment for ductus arteriosus were taken as control group. The clinical outcomes, complications and prognosis of these patients were observed. Results There were no significant differences between the gentle percentage, gestational age, diameter of ductus arteriosus, rate of complicated with heart failure, sepsis, neonatal respiratory distress syndrome and intraventricular hemorrhage of two groups (P>0.05, respectively). The ductus arteriosus closed in 33 patients of treatment group (78.6%) and in nine patients of control group (25.0%)(χ2=22.39,P=0.000). There were no significant differences in serum creatinine level and platelet count between before and after the treatment in treatment group(P>0.05). Compared with control group, the treatment group had lower incidence of intraventricular hemorrhage (z=1.167, P=0.030), shorter duration of oxygen therapy [(8.0±5.5) d vs (13.3±9.3) d, t=2.225, P=0.032] and shorter hospital stay [(39.0±7.7) d vs (43.6±10.6) d, t=2.229, P=0.029]; while the incidence of bronchopulmonary dysplasia and necrotizing enterocolitis were similar (P>0.05). The five cases of PDA who received video-assisted thoracoscopic surgery were successfully interrupted with no residual shunt left, while three of them had lung infections and one had pleural effusion, but no pneumothorax and infant death associated with surgery occurred. Conclusions Symptomatic PDA of very low birth weight preterm infants should be treated actively. Oral indomethacin was an effective and safe method to cure the PDA in these infants. Surgical ligation under video-assisted thoracoscopic surgery after failure of indomethacin treatment might be a good option.